Share Price and Basic Stock Data
Last Updated: December 9, 2025, 12:34 pm
| PEG Ratio | 10.57 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Navin Fluorine International Ltd operates in the chemicals sector, specializing in fluorochemicals, which are crucial for various industries including pharmaceuticals and agrochemicals. The company’s revenue trajectory has been noteworthy, with reported sales climbing from ₹1,453 Cr in FY 2022 to ₹2,077 Cr in FY 2023, reflecting a significant growth of 43%. However, the most recent figures from FY 2024 show a slight decline in revenue to ₹2,065 Cr, indicating potential headwinds or market saturation. The latest quarterly results for September 2023 reported sales of ₹472 Cr, a decline from ₹491 Cr in the previous quarter, which raises questions about the sustainability of growth in the near term. Despite these fluctuations, the company has maintained a robust operating profit margin (OPM) of 29%, underscoring its ability to manage costs effectively amidst changing market conditions.
Profitability and Efficiency Metrics
Profitability metrics for Navin Fluorine indicate a solid foundation, though recent trends reveal some volatility. The operating profit margin stood at 26% for FY 2025, a slight improvement from 23% in FY 2024, showcasing the company’s operational resilience. However, net profit margins have shown variability, declining to 12.28% in FY 2025 from 13.09% in FY 2024. This could suggest rising costs or competitive pressures that are squeezing margins. The interest coverage ratio (ICR) at 7.41x indicates a comfortable buffer for interest payments, suggesting that the company is managing its debt levels effectively. Nonetheless, the cash conversion cycle (CCC) at 89 days is somewhat extended, reflecting potential inefficiencies in inventory or receivables management that could impact liquidity.
Balance Sheet Strength and Financial Ratios
Examining the balance sheet, Navin Fluorine appears to be in a relatively healthy position, with total borrowings reported at ₹1,177 Cr against reserves of ₹3,591 Cr. This translates to a debt-to-equity ratio of approximately 0.54, indicating a prudent level of leverage. The company has also seen its book value per share increase to ₹529.48, up from ₹480.86 the previous year, reflecting retained earnings and solid equity management. However, the price-to-book ratio of 7.95x suggests that the stock may be trading at a premium compared to its intrinsic value. Investors need to weigh this valuation against the company’s profitability and growth prospects. Additionally, the return on equity (ROE) stands at 11.5%, which, while decent, is underwhelming compared to sector peers, potentially indicating room for improvement in generating shareholder returns.
Shareholding Pattern and Investor Confidence
The shareholding structure of Navin Fluorine reveals a diversified ownership landscape that can be indicative of investor confidence. Promoters hold 27.11% of the shares, while domestic institutional investors (DIIs) control 29.57%, and foreign institutional investors (FIIs) hold 22.15%. This suggests a balanced mix of ownership, which can provide stability to the stock price. Notably, the increase in DII holdings from 23.77% a year earlier to the current level reflects growing institutional interest, potentially driven by the company’s solid fundamentals. However, the gradual decline in promoter stake from 29.40% to 27.11% over the same period might raise questions about long-term commitment or strategic shifts. The number of shareholders has also decreased to 137,981, indicating a possible consolidation phase, which can have varying implications for liquidity and market sentiment.
Outlook, Risks, and Final Insight
Looking ahead, Navin Fluorine International faces a mix of opportunities and challenges. The company’s strong operational metrics and a solid balance sheet provide a foundation for growth, but the recent revenue fluctuations and declining profit margins are causes for concern. Investors should also consider potential risks such as rising raw material costs, regulatory changes, and competitive pressures that could impact profitability. Furthermore, while the company’s market positioning in fluorochemicals holds promise, the volatility in sales trends could signal underlying challenges in demand. As investors evaluate this stock, the focus should be on how effectively Navin Fluorine can navigate these headwinds while capitalizing on its strengths in cost management and operational efficiency. Monitoring quarterly performance and shifts in market dynamics will be crucial in assessing long-term investment viability.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Navin Fluorine International Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Diamines & Chemicals Ltd | 256 Cr. | 261 | 541/250 | 158 | 0.38 % | 3.33 % | 1.78 % | 10.0 | |
| Deco-Mica Ltd | 26.8 Cr. | 63.8 | 97.0/56.0 | 14.6 | 64.2 | 0.00 % | 11.8 % | 7.51 % | 10.0 |
| Andhra Sugars Ltd | 1,002 Cr. | 73.9 | 104/64.9 | 12.5 | 121 | 1.08 % | 3.54 % | 2.51 % | 2.00 |
| Tamil Nadu Petro Products Ltd | 915 Cr. | 102 | 130/63.6 | 9.14 | 109 | 1.18 % | 6.97 % | 5.10 % | 10.0 |
| SRF Ltd | 83,945 Cr. | 2,832 | 3,325/2,197 | 51.9 | 447 | 0.25 % | 12.3 % | 10.4 % | 10.0 |
| Industry Average | 13,633.11 Cr | 1,115.43 | 31.94 | 204.33 | 0.43% | 10.57% | 8.89% | 7.60 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 398 | 419 | 564 | 697 | 491 | 472 | 500 | 602 | 524 | 519 | 606 | 701 | 725 |
| Expenses | 298 | 325 | 408 | 495 | 377 | 373 | 424 | 492 | 423 | 411 | 459 | 522 | 519 |
| Operating Profit | 99 | 94 | 156 | 202 | 114 | 98 | 76 | 110 | 100 | 107 | 147 | 179 | 207 |
| OPM % | 25% | 22% | 28% | 29% | 23% | 21% | 15% | 18% | 19% | 21% | 24% | 26% | 29% |
| Other Income | 11 | 11 | 10 | 4 | 8 | 23 | 64 | 13 | 10 | 11 | 10 | 12 | 14 |
| Interest | 0 | 4 | 9 | 14 | 19 | 20 | 18 | 17 | 16 | 14 | 20 | 28 | 30 |
| Depreciation | 12 | 18 | 25 | 8 | 21 | 24 | 25 | 26 | 27 | 28 | 30 | 35 | 35 |
| Profit before tax | 97 | 83 | 131 | 184 | 82 | 77 | 97 | 79 | 68 | 77 | 108 | 127 | 155 |
| Tax % | 24% | 30% | 19% | 26% | 25% | 22% | 20% | 11% | 25% | 23% | 23% | 25% | 24% |
| Net Profit | 74 | 58 | 107 | 136 | 62 | 61 | 78 | 70 | 51 | 59 | 84 | 95 | 117 |
| EPS in Rs | 15.02 | 11.67 | 21.50 | 27.50 | 12.41 | 12.22 | 15.74 | 14.19 | 10.32 | 11.86 | 16.86 | 19.15 | 23.62 |
Last Updated: August 1, 2025, 4:30 pm
Below is a detailed analysis of the quarterly data for Navin Fluorine International Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 725.00 Cr.. The value appears strong and on an upward trend. It has increased from 701.00 Cr. (Mar 2025) to 725.00 Cr., marking an increase of 24.00 Cr..
- For Expenses, as of Jun 2025, the value is 519.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 522.00 Cr. (Mar 2025) to 519.00 Cr., marking a decrease of 3.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 207.00 Cr.. The value appears strong and on an upward trend. It has increased from 179.00 Cr. (Mar 2025) to 207.00 Cr., marking an increase of 28.00 Cr..
- For OPM %, as of Jun 2025, the value is 29.00%. The value appears strong and on an upward trend. It has increased from 26.00% (Mar 2025) to 29.00%, marking an increase of 3.00%.
- For Other Income, as of Jun 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Mar 2025) to 14.00 Cr., marking an increase of 2.00 Cr..
- For Interest, as of Jun 2025, the value is 30.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 28.00 Cr. (Mar 2025) to 30.00 Cr., marking an increase of 2.00 Cr..
- For Depreciation, as of Jun 2025, the value is 35.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 35.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 155.00 Cr.. The value appears strong and on an upward trend. It has increased from 127.00 Cr. (Mar 2025) to 155.00 Cr., marking an increase of 28.00 Cr..
- For Tax %, as of Jun 2025, the value is 24.00%. The value appears to be improving (decreasing) as expected. It has decreased from 25.00% (Mar 2025) to 24.00%, marking a decrease of 1.00%.
- For Net Profit, as of Jun 2025, the value is 117.00 Cr.. The value appears strong and on an upward trend. It has increased from 95.00 Cr. (Mar 2025) to 117.00 Cr., marking an increase of 22.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 23.62. The value appears strong and on an upward trend. It has increased from 19.15 (Mar 2025) to 23.62, marking an increase of 4.47.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 23, 2025, 2:24 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 486 | 592 | 680 | 742 | 913 | 996 | 1,062 | 1,179 | 1,453 | 2,077 | 2,065 | 2,349 | 2,551 |
| Expenses | 420 | 519 | 561 | 582 | 693 | 777 | 794 | 870 | 1,098 | 1,527 | 1,666 | 1,816 | 1,911 |
| Operating Profit | 66 | 72 | 118 | 159 | 220 | 219 | 268 | 309 | 356 | 550 | 399 | 534 | 640 |
| OPM % | 14% | 12% | 17% | 21% | 24% | 22% | 25% | 26% | 24% | 26% | 19% | 23% | 25% |
| Other Income | 31 | 29 | 23 | 55 | 88 | 34 | 29 | 94 | 38 | 36 | 107 | 44 | 47 |
| Interest | 6 | 3 | 4 | 3 | 1 | 1 | 2 | 2 | 2 | 28 | 75 | 78 | 93 |
| Depreciation | 22 | 20 | 22 | 30 | 40 | 28 | 37 | 44 | 48 | 63 | 96 | 119 | 128 |
| Profit before tax | 69 | 78 | 116 | 182 | 266 | 224 | 258 | 358 | 344 | 496 | 336 | 380 | 467 |
| Tax % | 21% | 26% | 28% | 25% | 32% | 34% | -56% | 31% | 24% | 24% | 19% | 24% | |
| Net Profit | 68 | 58 | 84 | 137 | 180 | 149 | 409 | 258 | 263 | 375 | 270 | 289 | 355 |
| EPS in Rs | 13.47 | 11.18 | 17.08 | 27.88 | 36.43 | 30.15 | 82.57 | 52.02 | 53.09 | 75.68 | 54.56 | 58.19 | 71.49 |
| Dividend Payout % | 24% | 29% | 25% | 23% | 27% | 26% | 13% | 21% | 21% | 16% | 27% | 12% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -14.71% | 44.83% | 63.10% | 31.39% | -17.22% | 174.50% | -36.92% | 1.94% | 42.59% | -28.00% | 7.04% |
| Change in YoY Net Profit Growth (%) | 0.00% | 59.53% | 18.27% | -31.71% | -48.61% | 191.72% | -211.42% | 38.86% | 40.65% | -70.59% | 35.04% |
Navin Fluorine International Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 17% |
| 3 Years: | 17% |
| TTM: | 22% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | -7% |
| 3 Years: | 3% |
| TTM: | 62% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 35% |
| 5 Years: | 19% |
| 3 Years: | 4% |
| 1 Year: | 42% |
| Return on Equity | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 14% |
| 3 Years: | 13% |
| Last Year: | 12% |
Last Updated: September 5, 2025, 11:35 am
Balance Sheet
Last Updated: December 4, 2025, 1:42 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 546 | 578 | 636 | 825 | 974 | 1,063 | 1,402 | 1,624 | 1,834 | 2,175 | 2,373 | 2,616 | 3,591 |
| Borrowings | 58 | 61 | 82 | 19 | 13 | 4 | 1 | 25 | 121 | 861 | 1,368 | 1,466 | 1,177 |
| Other Liabilities | 166 | 203 | 228 | 324 | 259 | 231 | 215 | 239 | 420 | 484 | 626 | 738 | 865 |
| Total Liabilities | 779 | 852 | 955 | 1,177 | 1,256 | 1,307 | 1,629 | 1,898 | 2,385 | 3,529 | 4,377 | 4,830 | 5,643 |
| Fixed Assets | 288 | 274 | 375 | 561 | 428 | 430 | 529 | 540 | 556 | 1,646 | 1,875 | 2,736 | 2,780 |
| CWIP | 6 | 60 | 20 | 17 | 20 | 39 | 39 | 95 | 742 | 279 | 711 | 355 | 550 |
| Investments | 230 | 171 | 170 | 239 | 428 | 427 | 195 | 99 | 118 | 44 | 495 | 480 | 798 |
| Other Assets | 255 | 346 | 390 | 360 | 380 | 410 | 866 | 1,163 | 969 | 1,561 | 1,296 | 1,259 | 1,515 |
| Total Assets | 779 | 852 | 955 | 1,177 | 1,256 | 1,307 | 1,629 | 1,898 | 2,385 | 3,529 | 4,377 | 4,830 | 5,643 |
Below is a detailed analysis of the balance sheet data for Navin Fluorine International Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 10.00 Cr..
- For Reserves, as of Sep 2025, the value is 3,591.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,616.00 Cr. (Mar 2025) to 3,591.00 Cr., marking an increase of 975.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1,177.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 1,466.00 Cr. (Mar 2025) to 1,177.00 Cr., marking a decrease of 289.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 865.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 738.00 Cr. (Mar 2025) to 865.00 Cr., marking an increase of 127.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 5,643.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,830.00 Cr. (Mar 2025) to 5,643.00 Cr., marking an increase of 813.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 2,780.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,736.00 Cr. (Mar 2025) to 2,780.00 Cr., marking an increase of 44.00 Cr..
- For CWIP, as of Sep 2025, the value is 550.00 Cr.. The value appears strong and on an upward trend. It has increased from 355.00 Cr. (Mar 2025) to 550.00 Cr., marking an increase of 195.00 Cr..
- For Investments, as of Sep 2025, the value is 798.00 Cr.. The value appears strong and on an upward trend. It has increased from 480.00 Cr. (Mar 2025) to 798.00 Cr., marking an increase of 318.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,515.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,259.00 Cr. (Mar 2025) to 1,515.00 Cr., marking an increase of 256.00 Cr..
- For Total Assets, as of Sep 2025, the value is 5,643.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,830.00 Cr. (Mar 2025) to 5,643.00 Cr., marking an increase of 813.00 Cr..
Notably, the Reserves (3,591.00 Cr.) exceed the Borrowings (1,177.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 8.00 | 11.00 | 36.00 | 140.00 | 207.00 | 215.00 | 267.00 | 284.00 | 235.00 | -311.00 | 398.00 | 533.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 68 | 74 | 81 | 68 | 62 | 63 | 75 | 88 | 90 | 99 | 91 | 90 |
| Inventory Days | 105 | 96 | 89 | 136 | 110 | 91 | 127 | 129 | 149 | 197 | 150 | 117 |
| Days Payable | 97 | 113 | 112 | 94 | 92 | 58 | 79 | 77 | 85 | 103 | 122 | 118 |
| Cash Conversion Cycle | 75 | 57 | 57 | 110 | 80 | 96 | 123 | 140 | 154 | 193 | 119 | 89 |
| Working Capital Days | 24 | 39 | 37 | 4 | 43 | 58 | 88 | 113 | 109 | 140 | 45 | 25 |
| ROCE % | 11% | 11% | 17% | 22% | 29% | 21% | 21% | 22% | 19% | 20% | 11% | 12% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Small Cap Fund | 1,500,000 | 2.31 | 853.11 | 700,000 | 2025-12-08 01:15:17 | 114.29% |
| Nippon India Small Cap Fund | 567,368 | 0.47 | 322.68 | N/A | N/A | N/A |
| Axis Small Cap Fund | 522,648 | 1.1 | 297.25 | N/A | N/A | N/A |
| DSP Small Cap Fund | 500,000 | 1.69 | 284.37 | N/A | N/A | N/A |
| Axis ELSS Tax Saver Fund | 376,903 | 0.61 | 214.36 | N/A | N/A | N/A |
| SBI MNC Fund | 280,000 | 2.67 | 159.25 | N/A | N/A | N/A |
| Aditya Birla Sun Life Small Cap Fund | 260,056 | 2.88 | 147.9 | N/A | N/A | N/A |
| Edelweiss Mid Cap Fund | 244,609 | 1.1 | 139.12 | N/A | N/A | N/A |
| Edelweiss Small Cap Fund | 210,627 | 2.26 | 119.79 | N/A | N/A | N/A |
| ICICI Prudential Commodities Fund | 201,440 | 3.59 | 114.57 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 58.20 | 54.57 | 75.70 | 53.12 | 52.03 |
| Diluted EPS (Rs.) | 58.14 | 54.49 | 75.44 | 53.08 | 51.96 |
| Cash EPS (Rs.) | 82.26 | 74.00 | 88.36 | 62.76 | 58.84 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 529.48 | 480.86 | 440.96 | 372.19 | 330.11 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 529.48 | 480.86 | 440.96 | 372.19 | 330.11 |
| Revenue From Operations / Share (Rs.) | 473.67 | 416.75 | 419.25 | 293.31 | 238.28 |
| PBDIT / Share (Rs.) | 116.42 | 91.65 | 118.27 | 79.52 | 78.46 |
| PBIT / Share (Rs.) | 92.34 | 72.24 | 105.63 | 69.85 | 69.53 |
| PBT / Share (Rs.) | 76.63 | 67.72 | 100.08 | 69.47 | 72.30 |
| Net Profit / Share (Rs.) | 58.19 | 54.59 | 75.72 | 53.09 | 49.91 |
| NP After MI And SOA / Share (Rs.) | 58.18 | 54.59 | 75.72 | 53.09 | 52.03 |
| PBDIT Margin (%) | 24.57 | 21.99 | 28.21 | 27.11 | 32.92 |
| PBIT Margin (%) | 19.49 | 17.33 | 25.19 | 23.81 | 29.18 |
| PBT Margin (%) | 16.17 | 16.24 | 23.87 | 23.68 | 30.34 |
| Net Profit Margin (%) | 12.28 | 13.09 | 18.06 | 18.10 | 20.94 |
| NP After MI And SOA Margin (%) | 12.28 | 13.09 | 18.06 | 18.10 | 21.83 |
| Return on Networth / Equity (%) | 10.98 | 11.35 | 17.17 | 14.26 | 15.76 |
| Return on Capital Employeed (%) | 11.69 | 10.17 | 17.40 | 17.29 | 20.29 |
| Return On Assets (%) | 5.97 | 6.18 | 10.63 | 11.02 | 13.57 |
| Long Term Debt / Equity (X) | 0.40 | 0.42 | 0.34 | 0.05 | 0.00 |
| Total Debt / Equity (X) | 0.54 | 0.56 | 0.38 | 0.05 | 0.00 |
| Asset Turnover Ratio (%) | 0.51 | 0.52 | 0.67 | 0.69 | 0.64 |
| Current Ratio (X) | 1.74 | 1.81 | 2.81 | 2.65 | 5.91 |
| Quick Ratio (X) | 1.38 | 1.38 | 1.91 | 1.98 | 5.02 |
| Inventory Turnover Ratio (X) | 6.77 | 2.15 | 2.47 | 3.15 | 3.33 |
| Dividend Payout Ratio (NP) (%) | 20.61 | 27.48 | 14.53 | 20.70 | 15.37 |
| Dividend Payout Ratio (CP) (%) | 14.58 | 20.28 | 12.45 | 17.51 | 13.12 |
| Earning Retention Ratio (%) | 79.39 | 72.52 | 85.47 | 79.30 | 84.63 |
| Cash Earning Retention Ratio (%) | 85.42 | 79.72 | 87.55 | 82.49 | 86.88 |
| Interest Coverage Ratio (X) | 7.41 | 6.09 | 21.30 | 207.38 | 211.21 |
| Interest Coverage Ratio (Post Tax) (X) | 4.70 | 3.93 | 14.63 | 139.46 | 126.93 |
| Enterprise Value (Cr.) | 22273.63 | 16732.36 | 21948.40 | 20235.45 | 13070.56 |
| EV / Net Operating Revenue (X) | 9.48 | 8.10 | 10.57 | 13.92 | 11.08 |
| EV / EBITDA (X) | 38.57 | 36.84 | 37.45 | 51.35 | 33.66 |
| MarketCap / Net Operating Revenue (X) | 8.88 | 7.47 | 10.17 | 13.92 | 11.54 |
| Retention Ratios (%) | 79.38 | 72.51 | 85.46 | 79.29 | 84.62 |
| Price / BV (X) | 7.95 | 6.47 | 9.67 | 10.97 | 8.33 |
| Price / Net Operating Revenue (X) | 8.88 | 7.47 | 10.17 | 13.92 | 11.54 |
| EarningsYield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
After reviewing the key financial ratios for Navin Fluorine International Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 58.20. This value is within the healthy range. It has increased from 54.57 (Mar 24) to 58.20, marking an increase of 3.63.
- For Diluted EPS (Rs.), as of Mar 25, the value is 58.14. This value is within the healthy range. It has increased from 54.49 (Mar 24) to 58.14, marking an increase of 3.65.
- For Cash EPS (Rs.), as of Mar 25, the value is 82.26. This value is within the healthy range. It has increased from 74.00 (Mar 24) to 82.26, marking an increase of 8.26.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 529.48. It has increased from 480.86 (Mar 24) to 529.48, marking an increase of 48.62.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 529.48. It has increased from 480.86 (Mar 24) to 529.48, marking an increase of 48.62.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 473.67. It has increased from 416.75 (Mar 24) to 473.67, marking an increase of 56.92.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 116.42. This value is within the healthy range. It has increased from 91.65 (Mar 24) to 116.42, marking an increase of 24.77.
- For PBIT / Share (Rs.), as of Mar 25, the value is 92.34. This value is within the healthy range. It has increased from 72.24 (Mar 24) to 92.34, marking an increase of 20.10.
- For PBT / Share (Rs.), as of Mar 25, the value is 76.63. This value is within the healthy range. It has increased from 67.72 (Mar 24) to 76.63, marking an increase of 8.91.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 58.19. This value is within the healthy range. It has increased from 54.59 (Mar 24) to 58.19, marking an increase of 3.60.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 58.18. This value is within the healthy range. It has increased from 54.59 (Mar 24) to 58.18, marking an increase of 3.59.
- For PBDIT Margin (%), as of Mar 25, the value is 24.57. This value is within the healthy range. It has increased from 21.99 (Mar 24) to 24.57, marking an increase of 2.58.
- For PBIT Margin (%), as of Mar 25, the value is 19.49. This value is within the healthy range. It has increased from 17.33 (Mar 24) to 19.49, marking an increase of 2.16.
- For PBT Margin (%), as of Mar 25, the value is 16.17. This value is within the healthy range. It has decreased from 16.24 (Mar 24) to 16.17, marking a decrease of 0.07.
- For Net Profit Margin (%), as of Mar 25, the value is 12.28. This value exceeds the healthy maximum of 10. It has decreased from 13.09 (Mar 24) to 12.28, marking a decrease of 0.81.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.28. This value is within the healthy range. It has decreased from 13.09 (Mar 24) to 12.28, marking a decrease of 0.81.
- For Return on Networth / Equity (%), as of Mar 25, the value is 10.98. This value is below the healthy minimum of 15. It has decreased from 11.35 (Mar 24) to 10.98, marking a decrease of 0.37.
- For Return on Capital Employeed (%), as of Mar 25, the value is 11.69. This value is within the healthy range. It has increased from 10.17 (Mar 24) to 11.69, marking an increase of 1.52.
- For Return On Assets (%), as of Mar 25, the value is 5.97. This value is within the healthy range. It has decreased from 6.18 (Mar 24) to 5.97, marking a decrease of 0.21.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.40. This value is within the healthy range. It has decreased from 0.42 (Mar 24) to 0.40, marking a decrease of 0.02.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.54. This value is within the healthy range. It has decreased from 0.56 (Mar 24) to 0.54, marking a decrease of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.51. It has decreased from 0.52 (Mar 24) to 0.51, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 1.74. This value is within the healthy range. It has decreased from 1.81 (Mar 24) to 1.74, marking a decrease of 0.07.
- For Quick Ratio (X), as of Mar 25, the value is 1.38. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.38.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.77. This value is within the healthy range. It has increased from 2.15 (Mar 24) to 6.77, marking an increase of 4.62.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 20.61. This value is within the healthy range. It has decreased from 27.48 (Mar 24) to 20.61, marking a decrease of 6.87.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 14.58. This value is below the healthy minimum of 20. It has decreased from 20.28 (Mar 24) to 14.58, marking a decrease of 5.70.
- For Earning Retention Ratio (%), as of Mar 25, the value is 79.39. This value exceeds the healthy maximum of 70. It has increased from 72.52 (Mar 24) to 79.39, marking an increase of 6.87.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 85.42. This value exceeds the healthy maximum of 70. It has increased from 79.72 (Mar 24) to 85.42, marking an increase of 5.70.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 7.41. This value is within the healthy range. It has increased from 6.09 (Mar 24) to 7.41, marking an increase of 1.32.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.70. This value is within the healthy range. It has increased from 3.93 (Mar 24) to 4.70, marking an increase of 0.77.
- For Enterprise Value (Cr.), as of Mar 25, the value is 22,273.63. It has increased from 16,732.36 (Mar 24) to 22,273.63, marking an increase of 5,541.27.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 9.48. This value exceeds the healthy maximum of 3. It has increased from 8.10 (Mar 24) to 9.48, marking an increase of 1.38.
- For EV / EBITDA (X), as of Mar 25, the value is 38.57. This value exceeds the healthy maximum of 15. It has increased from 36.84 (Mar 24) to 38.57, marking an increase of 1.73.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 8.88. This value exceeds the healthy maximum of 3. It has increased from 7.47 (Mar 24) to 8.88, marking an increase of 1.41.
- For Retention Ratios (%), as of Mar 25, the value is 79.38. This value exceeds the healthy maximum of 70. It has increased from 72.51 (Mar 24) to 79.38, marking an increase of 6.87.
- For Price / BV (X), as of Mar 25, the value is 7.95. This value exceeds the healthy maximum of 3. It has increased from 6.47 (Mar 24) to 7.95, marking an increase of 1.48.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 8.88. This value exceeds the healthy maximum of 3. It has increased from 7.47 (Mar 24) to 8.88, marking an increase of 1.41.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Navin Fluorine International Ltd:
- Net Profit Margin: 12.28%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 11.69% (Industry Average ROCE: 10.57%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 10.98% (Industry Average ROE: 8.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.7
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.38
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 64.8 (Industry average Stock P/E: 28.74)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.54
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 12.28%
Fundamental Analysis of Navin Fluorine International Ltd
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Others | Office No. 602, 6th floor, Natraj by, Rustomjee, Mumbai Maharashtra 400069 | info@nfil.in http://www.nfil.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Vishad P Mafatlal | Chairman |
| Mr. Radhesh R Welling | Managing Director |
| Mr. Ashok U Sinha | Director |
| Ms. Mohan M Nambiar | Director |
| Mr. Pradip N Kapadia | Director |
| Mr. Sunil S Lalbhai | Director |
| Mr. Sudhir G Mankad | Director |
| Mr. Harish H Engineer | Director |
| Mrs. Radhika V Haribhakti | Director |
| Mr. Atul K Srivastava | Director |
| Mr. Sujal A Shah | Director |
| Mr. Apurva S Purohit | Director |
Navin Fluorine International Ltd. Share Price Update | |
|---|---|
| Share Price | Value |
| Today | ₹3,386.30 |
| Previous Day | ₹3,429.25 |
FAQ
What is the intrinsic value of Navin Fluorine International Ltd?
Navin Fluorine International Ltd's intrinsic value (as of 09 December 2025) is 4200.23 which is 25.28% lower the current market price of 5,621.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 28,802 Cr. market cap, FY2025-2026 high/low of 6,169/3,180, reserves of ₹3,591 Cr, and liabilities of 5,643 Cr.
What is the Market Cap of Navin Fluorine International Ltd?
The Market Cap of Navin Fluorine International Ltd is 28,802 Cr..
What is the current Stock Price of Navin Fluorine International Ltd as on 09 December 2025?
The current stock price of Navin Fluorine International Ltd as on 09 December 2025 is 5,621.
What is the High / Low of Navin Fluorine International Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Navin Fluorine International Ltd stocks is 6,169/3,180.
What is the Stock P/E of Navin Fluorine International Ltd?
The Stock P/E of Navin Fluorine International Ltd is 64.8.
What is the Book Value of Navin Fluorine International Ltd?
The Book Value of Navin Fluorine International Ltd is 703.
What is the Dividend Yield of Navin Fluorine International Ltd?
The Dividend Yield of Navin Fluorine International Ltd is 0.22 %.
What is the ROCE of Navin Fluorine International Ltd?
The ROCE of Navin Fluorine International Ltd is 11.7 %.
What is the ROE of Navin Fluorine International Ltd?
The ROE of Navin Fluorine International Ltd is 11.5 %.
What is the Face Value of Navin Fluorine International Ltd?
The Face Value of Navin Fluorine International Ltd is 2.00.